Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onset of Efficacy of Azelastine 0.15% Nasal Spray in Allergic Rhinitis
NCT04264637Phase 3Completed
- Sponsor
- Bayer
- Start
- Feb 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azelastine in allergic rhinitis (AR), sponsored by Bayer. Started Feb 2020; status: completed.
02
Drugs
azelastine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT04264637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04264637.